| P2093 | author name string | Shibata R | |
| | Martin MA | |
| | Brady JN | |
| | Kashanchi F | |
| | Ross EK | |
| P2860 | cites work | Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat | Q24645992 |
| | Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat | Q24655684 |
| | Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells | Q27860607 |
| | Direct interaction of human TFIID with the HIV-1 transactivator tat | Q28250314 |
| | Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS | Q28262859 |
| | Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation | Q28303864 |
| | Phorbol ester enhances human immunodeficiency virus-promoted gene expression and acts on a repeated 10-base-pair functional enhancer element | Q40671496 |
| | Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro. | Q41079020 |
| | Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex | Q42468497 |
| | Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1. | Q42735234 |
| | Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. | Q43858457 |
| | Expression and characterization of the trans-activator of HTLV-III/LAV virus | Q45831293 |
| | Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. | Q48365300 |
| | The Fos complex and Fos-related antigens recognize sequence elements that contain AP-1 binding sites | Q57963304 |
| | Characterization of cellular proteins recognizing the HIV enhancer using a microscale DNA-affinity precipitation assay | Q59097038 |
| | The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level | Q70213932 |
| | Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 |
| | An inducible transcription factor activates expression of human immunodeficiency virus in T cells | Q29618434 |
| | Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay | Q29619255 |
| | HIV-1 Tat protein trans-activates transcription in vitro | Q30411837 |
| | Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro | Q33584734 |
| | In vitro activation of the HIV-1 enhancer in extracts from cells treated with a phorbol ester tumor promoter. | Q33930106 |
| | Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression | Q33936851 |
| | Distinct TFIID complexes mediate the effect of different transcriptional activators | Q34043048 |
| | Unique TATA-binding protein-containing complexes and cofactors involved in transcription by RNA polymerases II and III | Q34055015 |
| | A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. | Q34059393 |
| | Identification of a putative regulator of early T cell activation genes | Q34171263 |
| | Compilation and analysis of eukaryotic POL II promoter sequences | Q34191315 |
| | Human immunodeficiency virus long terminal repeat responds to T-cell activation signals | Q34350307 |
| | The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat | Q34564367 |
| | Activation of class II gene transcription by regulatory factors is potentiated by a novel activity | Q34855093 |
| | DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract. | Q36396364 |
| | Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the -201 to -130 region of the long terminal repeat | Q36644443 |
| | Association of human immunodeficiency virus type 1 envelope glycoprotein with particles depends on interactions between the third variable and conserved regions of gp120. | Q36649075 |
| | Amino acid changes in the fourth conserved region of human immunodeficiency virus type 2 strain HIV-2ROD envelope glycoprotein modulate fusion | Q36653891 |
| | Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes | Q36682395 |
| | Changes in both gp120 and gp41 can account for increased growth potential and expanded host range of human immunodeficiency virus type 1 | Q36699051 |
| | Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types | Q36797366 |
| | Deletions in the tRNA(Lys) primer-binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription | Q36797561 |
| | Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. | Q36812220 |
| | In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity | Q36825840 |
| | Functional interaction of constant and variable domains of human immunodeficiency virus type 1 gp120. | Q36830136 |
| | Effects of long terminal repeat mutations on human immunodeficiency virus type 1 replication | Q36830870 |
| | The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. | Q36831819 |
| | Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus | Q37546388 |
| | The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by Tat | Q38320497 |
| | Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter | Q38325574 |
| | Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation | Q38345116 |
| | Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus | Q38348287 |
| | Chicken ovalbumin upstream promoter transcription factor binds to a negative regulatory region in the human immunodeficiency virus type 1 long terminal repeat. | Q40064606 |
| | Different TBP-associated factors are required for mediating the stimulation of transcription in vitro by the acidic transactivator GAL-VP16 and the two nonacidic activation functions of the estrogen receptor. | Q40404523 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | infectivity | Q1662346 |
| P304 | page(s) | 3298-3307 | |
| P577 | publication date | 1994-05-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA | |
| P478 | volume | 68 | |